Multisystem Inflammatory Syndrome in Children Is a Serious Coronavirus Risk

An inflammation syndrome in some children exposed to COVID-19 may serve as a warning to vaccine developers, a University of Virginia researcher and his colleagues said to the DailyProgress on September 27, 2020. 

New research findings of the multisystem inflammatory syndrome in children, known as MIS-C, show that children with the condition have elevated levels of antibodies that their bodies created to fight the proteins the COVID-causing virus uses to infect a body. Furthermore, these researchers say it’s important that the findings be considered as labs everywhere race to bring a vaccine to market.

The exact cause of MIS-C and whether the increased antibodies are a cause or an effect of the condition is not known, says the U.S. CDC.

Separately, a study published by The Lancet on September 4, 2020, reviewed 39 observational studies and concluded saying 'MIS-C is a new pediatric disease associated with SARS-CoV-2 that is dangerous and potentially lethal. With prompt recognition and medical attention, most children will survive but the long-term outcomes from this condition are presently unknown.'